Nantahala Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,439
| Closed | -$412K | – | 110 |
|
|
2022
Q1 | $412K | Sell |
1,439
-216
| -13% | -$61.8K | 0.02% | 93 |
|
|
2021
Q4 | $542K | Sell |
1,655
-427
| -21% | -$140K | 0.02% | 98 |
|
|
2021
Q3 | $1.05M | Sell |
2,082
-3,166
| -60% | -$1.59M | 0.03% | 94 |
|
|
2021
Q2 | $2.87M | Sell |
5,248
-1,494
| -22% | -$818K | 0.08% | 82 |
|
|
2021
Q1 | $4.16M | Sell |
6,742
-3,963
| -37% | -$2.45M | 0.12% | 69 |
|
|
2020
Q4 | $5.99M | Sell |
10,705
-810
| -7% | -$453K | 0.19% | 76 |
|
|
2020
Q3 | $7.32M | Hold |
11,515
| – | – | 0.22% | 61 |
|
|
2020
Q2 | $9.91M | Buy |
11,515
+4,272
| +59% | +$3.68M | 0.3% | 47 |
|
|
2020
Q1 | $4.51M | Buy |
7,243
+2,359
| +48% | +$1.47M | 0.17% | 58 |
|
|
2019
Q4 | $5.08M | Hold |
4,884
| – | – | 0.16% | 55 |
|
|
2019
Q3 | $4.2M | Hold |
4,884
| – | – | 0.16% | 59 |
|
|
2019
Q2 | $6.56M | Buy |
4,884
+469
| +11% | +$630K | 0.2% | 51 |
|
|
2019
Q1 | $6.49M | Sell |
4,415
-221
| -5% | -$325K | 0.2% | 53 |
|
|
2018
Q4 | $5.7M | Sell |
4,636
-23
| -0.5% | -$28.3K | 0.18% | 53 |
|
|
2018
Q3 | $11.4M | Buy |
4,659
+542
| +13% | +$1.32M | 0.31% | 31 |
|
|
2018
Q2 | $8.82M | Buy |
4,117
+2,402
| +140% | +$5.15M | 0.36% | 37 |
|
|
2018
Q1 | $1.72M | Sell |
1,715
-507
| -23% | -$508K | 0.08% | 57 |
|
|
2017
Q4 | $3.66M | Buy |
+2,222
| New | +$3.66M | 0.16% | 40 |
|